CE Credit | Hepatitis C Online | 7 | Special Topics

The treatment landscape for hepatic C is rapidly changing. Learn about
three medications not yet FDA-approved that show promise for treating genotype 1 HCV.

The Hepatitis C Online Course is funded by a grant from the Centers for Disease Control and Prevention and is offered for free to healthcare professionals. 

Publish Date: May 6, 2014. This course will be available for three years from this date.

 

 

Learning objectives

  • Increase awareness of future therapies available for the treatment of hepatitis C.
  • Summarize major drugs in development for the treatment of hepatitis C.
  • Discuss key concepts of HCV protease inhibitor resistance. 

Target Audience

Clinicians who play a substantial role in the long-term management of patients with chronic hepatitis C virus (HCV) infection, including primary care physicians, advanced registered nurse practitioners, physician assistants, infectious diseases specialists, gastroenterologists and hepatologists

Additional Information

Format: 
Reading
Video
Course summary
Maximum credit available: 
  • 0.75 Contact hours
  • 0.00 Pharmacology hours at the advanced practice level
Available: 
05/06/2014
Expires: 
05/06/2017

Available Credit

  • 0.75 Contact hours
  • 0.00 Pharmacology hours at the advanced practice level
 
Status
Price
Title
$0.00Included
Please login or create account to take this course.
$0.00Included
Please login or create account to take this course.
Please login or create account to take this course.